About
Our Mission
Leadership
Partners
Our Technologies
TALEN® Technology
Gene Editing
PulseAgile Technology
Patents
Pipeline
Products
Clinical Indications
Manufacturing
Investors
Press Releases
Corporate presentation & ESG report
Scientific Presentations
Scientific Publications
Events and Webcasts
2021 Cellectis Innovation Days
Stock Information
Corporate Governance
Governance Documents
Board of Directors & Committee Members
Shareholders Meeting
SEC Filings
Contact
IR Inquiries
Email Alerts
Investor FAQ
Careers
Our Culture
Job Opportunities
Contact us
fr
Press Releases
Our latest news and press releases
Press releases
Corporate presentation
Scientific Presentations
Scientific Publications
Events and webcasts
Stock information
SEC filings
Financial Statements
Regulated information
Voting Rights & Share Capital
ATM Program
General meetings
Governance
The board and committee members
Corporate governance documents
FAQ
IR Inquiry
All
2024
2023
2022
2021
2020
28
Jun 2022
16:30 E.S.T.
Cellectis Announces the Appointment of Axel-Sven Malkomes & Dr. Donald A Bergstrom, M.D., Ph.D., to its Board of Directors
Read more
28
Jun 2022
16:05 E.S.T.
Cellectis S.A. Reports Results from Annual Shareholders’ General Meeting Held on June 28, 2022
Read more
23
May 2022
16:30 E.S.T.
Cellectis’ Annual Shareholders’ General Meeting to be Held on June 28, 2022
Read more
16
May 2022
08:30 E.S.T.
Cellectis Presents Research Data on a Novel Immune-Evasive Universal CAR T-cell at ASGCT
Read more
12
May 2022
16:30 E.S.T.
Cellectis Provides Business Update and Reports Financial Results for First Quarter 2022
Read more
05
May 2022
16:30 E.S.T.
Cellectis to Report First Quarter 2022 Financial Results
Read more
Prev
2
3
4
5
6
Next